Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0293 USD | -2.33% | -2.33% | -95.82% |
May. 30 | First Motion for Exclusivity Period Extension Filed by DMK Pharmaceuticals Corporation | CI |
May. 08 | Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-95.82% | 303K | |
+42.42% | 739B | |
+32.72% | 598B | |
-5.29% | 353B | |
+17.78% | 318B | |
+5.17% | 285B | |
+16.53% | 240B | |
+9.50% | 210B | |
-5.32% | 206B | |
+7.88% | 164B |
- Stock Market
- Equities
- DMKPQ Stock
- News DMK Pharmaceuticals Corporation
- Transcript : Adamis Pharmaceuticals Corporation, Q1 2023 Earnings Call, May 15, 2023